Illumina (NASDAQ:ILMN) on Monday lowered its adjusted profit outlook and cut spending costs for 2025 as the company grapples with a Chinese ban on its gene sequencers. Illumina now expects fiscal ...

Illumina generates about 7% of its revenue from China, where it competes with domestic Chinese sequencing companies, according to Leerink Partners analysts. China’s Ministry of Commerce announcement ...

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

Those companies are Chinese sequencers MGI and BGI. The Chinese companies, MGI and BGI, were among five biotech firms targeted in the U.S. Biosecure Act, a bill that seeks to reduce the United ...

The import ban on Illumina’s NGS sequencers follows its placement on China’s Ministry of Commerce’s (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock. China has ...

SHANGHAI - China announced a ban on March 4 on imports of genetic sequencers from US medical equipment maker Illumina, just minutes after US President Donald Trump’s additional 10 per cent ...

While in positive territory ahead of Tuesday's market close, Illumina (ILMN) shares have fallen to a 52-week low after Chinese officials banned imports of its genetic sequencing equipment ...

Follow us on Facebook and join our Telegram channel for the latest updates. China banned the import of Illumina gene-sequencing machines as part of a wave of retaliatory measures against fresh US ...

ILUSTRASI. China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina. CHINA - SHANGHAI. China announced a ban on Tuesday on imports of genetic ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese ...